TY - STD TI - Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J, Freund KB, Sorenson J, Orlock D, Borodoker N. Retinal angiomatous proliferation in age-related macular degeneration. Retina (Philadelphia, Pa). 2001;21(5):416–34. ID - ref1 ER - TY - STD TI - Viola F, Massacesi A, Orzalesi N, Ratiglia R, Staurenghi G. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina (Philadelphia, Pa). 2009;29(6):732–9. ID - ref2 ER - TY - STD TI - Sawa M, Ueno C, Gomi F, Nishida K. Incidence and characteristics of neovascularization in fellow eyes of Japanese patients with unilateral retinal angiomatous proliferation. Retina (Philadelphia, Pa). 2014;347(4):761–7. ID - ref3 ER - TY - STD TI - Cohen SY, Creuzot-Garcher C, Darmon J, Desmettre T, Korobelnik JF, Levrat F, et al. Types of choroidal neovascularisation in newly diagnosed exudative age-related macular degeneration. Br J Ophthalmol. 2007;91(9):1173–6. ID - ref4 ER - TY - JOUR AU - Maruko, I. AU - Iida, T. AU - Saito, M. AU - Nagayama, D. AU - Saito, K. PY - 2007 DA - 2007// TI - Clinical characteristics of exudative age-related macular degeneration in Japanese patients JO - Am J Ophthalmol VL - 144 UR - https://doi.org/10.1016/j.ajo.2007.03.047 DO - 10.1016/j.ajo.2007.03.047 ID - Maruko2007 ER - TY - STD TI - Sakurada Y, Yoneyama S, Sugiyama A, Tanabe N, Kikushima W, Mabuchi F, et al. Prevalence and genetic characteristics of geographic atrophy among elderly Japanese with age-related macular degeneration. PLoS One. 2016;11(2):e0149978. ID - ref6 ER - TY - STD TI - Johnson TM, Glaser BM. Focal laser ablation of retinal angiomatous proliferation. Retina (Philadelphia, Pa). 2006;26(7):765–72. ID - ref7 ER - TY - JOUR AU - Sakimoto, S. AU - Gomi, F. AU - Sakaguchi, H. AU - Tano, Y. PY - 2005 DA - 2005// TI - Recurrent retinal angiomatous proliferation after surgical ablation JO - Am J Ophthalmol VL - 139 UR - https://doi.org/10.1016/j.ajo.2004.10.046 DO - 10.1016/j.ajo.2004.10.046 ID - Sakimoto2005 ER - TY - STD TI - Shiragami C, Iida T, Nagayama D, Baba T, Shiraga F. Recurrence after surgical ablation for retinal angiomatous proliferation. Retina (Philadelphia, Pa). 2007;27(2):198–203. ID - ref9 ER - TY - STD TI - Kuroiwa S, Arai J, Gaun S, Iida T, Yoshimura N. Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina (Philadelphia, Pa). 2003;23(3):417–20. ID - ref10 ER - TY - JOUR AU - Boscia, F. AU - Furino, C. AU - Sborgia, L. AU - Reibaldi, M. AU - Sborgia, C. PY - 2004 DA - 2004// TI - Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment JO - Am J Ophthalmol VL - 138 UR - https://doi.org/10.1016/j.ajo.2004.06.072 DO - 10.1016/j.ajo.2004.06.072 ID - Boscia2004 ER - TY - STD TI - Silva RM, Cachulo ML, Figueira J, de Abreu JR, Cunha-Vaz JG. Chorioretinal anastomosis and photodynamic therapy: a two-year follow-up study. Graefe's Arch Clin Exper Ophthalmol. 2007;245(8):1131–9. ID - ref12 ER - TY - STD TI - Saito M, Shiragami C, Shiraga F, Kano M, Iida T. Comparison of intravitreal triamcinolone acetonide with photodynamic therapy and intravitreal bevacizumab with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol. 2010;149(3):472–481.e471. ID - ref13 ER - TY - STD TI - Gharbiya M, Parisi F, Cruciani F, Bozzoni-Pantaleoni F, Pranno F, Abdolrahimzadeh S. Intravitreal anti-vascular endothelial growth factor for retinal angiomatous proliferation in treatment-naive eyes: long-term functional and anatomical results using a modified PrONTO-style regimen. Retina (Philadelphia, Pa). 2014;34(2):298–305. ID - ref14 ER - TY - JOUR AU - Hemeida, T. S. AU - Keane, P. A. AU - Dustin, L. AU - Sadda, S. R. AU - Fawzi, A. A. PY - 2010 DA - 2010// TI - Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation JO - Br J Ophthalmol VL - 94 UR - https://doi.org/10.1136/bjo.2009.167627 DO - 10.1136/bjo.2009.167627 ID - Hemeida2010 ER - TY - STD TI - Gharbiya M, Allievi F, Recupero V, Martini D, Mazzeo L, Gabrieli CB. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina (Philadelphia, Pa). 2009;29(6):740–9. ID - ref16 ER - TY - STD TI - Schmidt-Erfurth U, Kaiser PK, Korobelnik JF, Brown DM, Chong V, Nguyen QD, et al. Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies. Ophthalmology. 2014;121(1):193–201. ID - ref17 ER - TY - STD TI - Matsumoto H, Sato T, Morimoto M, Mukai R, Takahashi M, Hiroe T, Ehara K, Takayama M, Mimura K, Kishi S. Treat-and-extend regimen with aflibercept for retinal angiomatous proliferation. Retina (Philadelphia, Pa). 2016;36(12):2282–9. ID - ref18 ER - TY - STD TI - Dirani A, Ambresin A, Marchionno L, Decugis D, Mantel I. Factors Influencing the Treatment Response of Pigment Epithelium Detachment in Age-Related Macular Degeneration. Am J Ophthalmol. 2015;160(4):732–738.e732. ID - ref19 ER - TY - STD TI - Oishi A, Tsujikawa A, Yamashiro K, Ooto S, Tamura H, Nakanishi H, Ueda-Arakawa N, Miyake M, Akagi-Kurashige Y, Hata M, et al. One-year result of aflibercept treatment on age-related macular degeneration and predictive factors for visual outcome. Am J ophthalmol. 2015;159(5):853–860.e851. ID - ref20 ER - TY - STD TI - Nagiel A, Sarraf D, Sadda SR, Spaide RF, Jung JJ, Bhavsar KV, Ameri H, Querques G, Freund KB. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography. Retina (Philadelphia, Pa). 2015;35(4):638–47. ID - ref21 ER - TY - STD TI - Ravera V, Bottoni F, Giani A, Cigada M, Staurenghi G. Retinal angiomatous proliferation diagnosis: a multiimaging approach. Retina (Philadelphia, Pa). 2016;36(12):2274–81. ID - ref22 ER - TY - STD TI - Tsai AS, Cheung N, Gan AT, Jaffe GJ, Sivaprasad S, Wong TY, et al. Retinal angiomatous proliferation. Survey of ophthalmology. 2017. ID - ref23 ER - TY - STD TI - Boscia F, Parodi MB, Furino C, Reibaldi M, Sborgia C. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefe's Arch Clin Exper Ophthalmol. 2006;244(10):1224–32. ID - ref24 ER - TY - JOUR AU - Inoue, M. AU - Arakawa, A. AU - Yamane, S. AU - Kadonosono, K. PY - 2014 DA - 2014// TI - Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography JO - Br J Ophthalmol VL - 98 UR - https://doi.org/10.1136/bjophthalmol-2013-304251 DO - 10.1136/bjophthalmol-2013-304251 ID - Inoue2014 ER - TY - STD TI - Rouvas AA, Chatziralli IP, Theodossiadis PG, Moschos MM, Kotsolis AI, Ladas ID. Long-term results of intravitreal ranibizumab, intravitreal ranibizumab with photodynamic therapy, and intravitreal triamcinolone with photodynamic therapy for the treatment of retinal angiomatous proliferation. Retina (Philadelphia, Pa). 2012;32(6):1181–9. ID - ref26 ER - TY - STD TI - Cho HJ, Lee TG, Han SY, Kim HS, Kim JH, Han JI, Lew YJ, Kim JW. Long-term visual outcome and prognostic factors of Intravitreal anti-vascular endothelial growth factor treatment for retinal angiomatous proliferation. Graefe's Arch Clin Exper Ophthalmol. 2016;254(1):23–30. ID - ref27 ER - TY - STD TI - Parodi MB, Iacono P, Menchini F, Sheth S, Polini G, Pittino R, et al. Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation. Acta Ophthalmol. 2013;91(3):267–73. ID - ref28 ER - TY - STD TI - Cho HJ, Kim HS, Yoo SG, Han JI, Lew YJ, Cho SW, Lee TG, Kim JW. Retinal Pigment Epithelial Tear After Intravitreal Ranibizumab Treatment for Retinal Angiomatous Proliferation. Am J Ophthalmol. 2015;160(5):1000–1005.e1002. ID - ref29 ER - TY - STD TI - Cho HJ, Yoo SG, Kim HS, Kim JH, Kim CG, Lee TG, Kim JW. Risk factors for geographic atrophy after intravitreal ranibizumab injections for retinal angiomatous proliferation. Am J Ophthalmol. 2015;159(2):285–292.e281. ID - ref30 ER - TY - STD TI - Hata M, Oishi A, Tsujikawa A, Yamashiro K, Miyake M, Ooto S, et al. Efficacy of intravitreal injection of aflibercept in neovascular age-related macular degeneration with or without choroidal vascular hyperpermeability. Invest Ophthalmol Vis Sci. 2014;55(12):7874–80. ID - ref31 ER - TY - STD TI - Chang AA, Li H, Broadhead GK, Hong T, Schlub TE, Wijeyakumar W, et al. Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration. Ophthalmology. 2014;121(1):188–92. ID - ref32 ER - TY - JOUR AU - Wykoff, C. C. AU - Brown, D. M. AU - Maldonado, M. E. AU - Croft, D. E. PY - 2014 DA - 2014// TI - Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial) JO - Br J Ophthalmol VL - 98 UR - https://doi.org/10.1136/bjophthalmol-2013-304736 DO - 10.1136/bjophthalmol-2013-304736 ID - Wykoff2014 ER - TY - STD TI - Simader C, Ritter M, Bolz M, Deak GG, Mayr-Sponer U, Golbaz I, et al. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration. Ophthalmology. 2014;121(6):1237–45. ID - ref34 ER - TY - JOUR AU - Schmidt-Erfurth, U. AU - Waldstein, S. M. AU - Deak, G. G. AU - Kundi, M. AU - Simader, C. PY - 2015 DA - 2015// TI - Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration JO - Ophthalmology VL - 122 UR - https://doi.org/10.1016/j.ophtha.2014.11.017 DO - 10.1016/j.ophtha.2014.11.017 ID - Schmidt-Erfurth2015 ER - TY - JOUR AU - Cho, H. J. AU - Kim, K. M. AU - Kim, H. S. AU - Lee, D. W. AU - Kim, C. G. AU - Kim, J. W. PY - 2016 DA - 2016// TI - Response of pigment epithelial detachment to anti-vascular endothelial growth factor treatment in age-related macular degeneration JO - Am J Ophthalmol VL - 166 UR - https://doi.org/10.1016/j.ajo.2016.03.039 DO - 10.1016/j.ajo.2016.03.039 ID - Cho2016 ER - TY - STD TI - Tsaousis KT, Konidaris VE, Banerjee S, Empeslidis T. Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 2015;253(4):663–5. ID - ref37 ER - TY - STD TI - Broadhead GK, Hong T, Zhu M, Li H, Schlub TE, Wijeyakumar W, Chang AA. Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration. Retina (Philadelphia, Pa). 2015;35(5):975–81. ID - ref38 ER - TY - STD TI - Patel KH, Chow CC, Rathod R, Mieler WF, Lim JI, Ulanski LJ, 2nd, Leiderman YI, Arun V, Chau FY. Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab. Eye (London, England). 2013;27(5):663–7; quiz 668. ID - ref39 ER - TY - JOUR AU - Shah, A. R. AU - Priore, L. V. PY - 2009 DA - 2009// TI - Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements JO - Br J Ophthalmol VL - 93 UR - https://doi.org/10.1136/bjo.2008.149674 DO - 10.1136/bjo.2008.149674 ID - Shah2009 ER - TY - STD TI - Tufail A, Patel PJ, Egan C, Hykin P, da Cruz L, Gregor Z, Dowler J, Majid MA, Bailey C, Mohamed Q, et al. Bevacizumab for neovascular age related macular degeneration (ABC Trial): multicentre randomised double masked study. BMJ (Clinical research ed). 2010;340:c2459. ID - ref41 ER - TY - STD TI - Moja L, Lucenteforte E, Kwag KH, Bertele V, Campomori A, Chakravarthy U, D'Amico R, Dickersin K, Kodjikian L, Lindsley K, et al. Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2014(9):Cd011230. ID - ref42 ER -